Cano Health, Inc.
CANO · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $134 | $734 | $458 | $670 |
| - Cash | $41 | $28 | $45 | $27 |
| + Debt | $1,241 | $1,232 | $1,218 | $1,200 |
| Enterprise Value | $1,334 | $1,938 | $1,631 | $1,842 |
| Revenue | $788 | $767 | $867 | $680 |
| % Growth | 2.8% | -11.6% | 27.4% | – |
| Gross Profit | $16 | -$60 | $90 | $107 |
| % Margin | 2% | -7.8% | 10.4% | 15.7% |
| EBITDA | -$435 | -$220 | -$9 | -$1 |
| % Margin | -55.3% | -28.6% | -1.1% | -0.1% |
| Net Income | -$260 | -$141 | -$28 | -$302 |
| % Margin | -33.1% | -18.4% | -3.2% | -44.3% |
| EPS Diluted | -49.35 | -26.67 | -5.59 | -61.7 |
| % Growth | -85% | -377.1% | 90.9% | – |
| Operating Cash Flow | -$40 | -$15 | -$29 | -$62 |
| Capital Expenditures | -$7 | -$6 | -$5 | -$10 |
| Free Cash Flow | -$47 | -$22 | -$35 | -$73 |